Kenneth Abramowitz

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Kenneth Abramowitz's primary investment focus based on startupim data?

Kenneth Abramowitz's primary investment focus is in the Health Tech & Life Sciences sector, as indicated by his sole portfolio company and investment round in this area.

Which company is a notable portfolio company for Kenneth Abramowitz?

Entera Bio is a notable portfolio company for Kenneth Abramowitz, having received a $5 million investment in February 2014.

What was the investment stage for Kenneth Abramowitz's investment in Entera Bio?

Kenneth Abramowitz's investment in Entera Bio in February 2014 was at the Seed stage.

Has Kenneth Abramowitz acted as a lead investor in any rounds?

No, according to startupim data, Kenneth Abramowitz has not acted as a lead investor in any of his recorded investment rounds.

What is the recorded investment range for Kenneth Abramowitz?

Kenneth Abramowitz's recorded investment range is $5M - $5M, based on the single investment documented.

Has Kenneth Abramowitz had any exits from his portfolio companies?

Yes, Kenneth Abramowitz had an exit in July 2018 when portfolio company Entera Bio went public on NASDAQ with a valuation of $91M.

When did Kenneth Abramowitz make his first recorded investment?

Kenneth Abramowitz made his first recorded investment in February 2014.

What was the total capital raised by Entera Bio at the time of its IPO, in which Kenneth Abramowitz was an investor?

At the time of its IPO in July 2018, Entera Bio had raised $11M in capital.